Org.nr 932 758 784 2024 → 2025 Year-over-year analysis

AB-FARMA AS: årsregnskap 2025 vs 2024

Returned to profit

approved 2026-06-30; registry 2026-08-01; journal 2026 734253

Full company analysis · All year comparisons

What changed

Comparing Årsregnskap 2025 with 2024 for AB-FARMA AS. Revenue 0 NOK → 0 NOK (0.0%). Net result -40.1k NOK → +6.91m NOK. Equity -20.7k NOK → 6.89m NOK.

On the constructive side: operating result improved; turned profitable; equity strengthened.

Also worth watching: book investments changed. All figures are taken from the published annual accounts for AB-FARMA AS.

Scorecard

Revenue
0 NOK 0 NOK
0.0%
Operating result
-35.1k NOK -33.4k NOK
+4.9%
Net result
-40.1k NOK +6.91m NOK
+17317.8%
Equity
-20.7k NOK 6.89m NOK
+33299.0%
Cash
9 261 NOK 49.6k NOK
+435.1%
Total assets
8.11m NOK 9.63m NOK
+18.7%

What improved

  • ↑

    Operating result improved

    Operating result -35.1k NOK → -33.4k NOK. Calculated

  • ↑

    Turned profitable

    Net result flipped from a loss of 40.1k NOK to a profit of 6.91m NOK. Calculated

  • ↑

    Equity strengthened

    Book equity -20.7k NOK → 6.89m NOK (equity ratio -0.3% → 71.5%). Calculated

  • ↑

    Cash rose

    Bank deposits 9 261 NOK → 49.6k NOK (+435.1% YoY). Calculated

Things to notice

  • ·

    Book investments changed

    Investment / intangible book value 8.00m NOK → 250.0k NOK. Reported fact